People
Some of the biggest hubs for biotech and pharma fared poorly in the rankings due to housing affordability.
Biopharma companies add new leaders to executive roles and boards of directors.
Early detection of cardiovascular disease is becoming possible due to research from Giovanna Guidoboni, Marjorie Skubic and a team at the University of Missouri.
“ALS is a disease you really want to make a difference in,” Toby Ferguson Biogen’s senior medical director for Neuromuscular Research and Early Development told BioSpace.
Clinical Ink is pleased to announce that Jonathan Andrus, Chief Business Officer at Clinical Ink, will receive the 2019 Excellence in Service Award from the Drug Information Association’s (DIA) Americas Regional Advisory Council.
Ms. Poole brings more than 25 years of biopharmaceutical product development and manufacturing experience to Retrophin
Antibe Therapeutics Chief Executive Officer Dan Legault likened developing an effective pain medication that is non-addictive and non-toxic to mountain climbers attempting to climb Mt. Everest.
As senior vice president of global operations, Sridhar will be responsible for integrating business units and provide operational excellence leadership across the Frontage organization
Esperion today announced that the company will participate in analyst-led fireside chats with investors at the following conferences
Peter Rowe, Deep Branch Biotechnology’s co-founder and Commercial Lead, took time to speak with BioSpace about his company, its progress, and where it’s headed.
PRESS RELEASES